These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 3041097

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Efficacy and variability of the antiproteinuric effect of ACE inhibition by lisinopril.
    Heeg JE, de Jong PE, van der Hem GK, de Zeeuw D.
    Kidney Int; 1989 Aug; 36(2):272-9. PubMed ID: 2550696
    [Abstract] [Full Text] [Related]

  • 4. Additive antiproteinuric effect of angiotensin-converting enzyme inhibition and non-steroidal anti-inflammatory drug therapy: a clue to the mechanism of action.
    Heeg JE, de Jong PE, de Zeeuw D.
    Clin Sci (Lond); 1991 Sep; 81(3):367-72. PubMed ID: 1655338
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Additive antiproteinuric effect of the NSAID indomethacin and the ACE inhibitor lisinopril.
    Heeg JE, de Jong PE, Vriesendorp R, de Zeeuw D.
    Am J Nephrol; 1990 Sep; 10 Suppl 1():94-7. PubMed ID: 2175149
    [Abstract] [Full Text] [Related]

  • 7. Add-on angiotensin receptor blockade with maximized ACE inhibition.
    Agarwal R.
    Kidney Int; 2001 Jun; 59(6):2282-9. PubMed ID: 11380832
    [Abstract] [Full Text] [Related]

  • 8. Hemodynamic responses to converting enzyme inhibition in patients with renal disease.
    August P, Cody RJ, Sealey JE, Laragh JH.
    Am J Hypertens; 1989 Aug; 2(8):599-603. PubMed ID: 2550029
    [Abstract] [Full Text] [Related]

  • 9. Effect of increasing doses of lisinopril on proteinuria of normotensive patients with IgA nephropathy and normal renal function.
    Palla R, Panichi V, Finato V, Parrini M, Andreini B, Bianchi AM, Giovannini L, Migliori M, Bertelli AA.
    Int J Clin Pharmacol Res; 1994 Aug; 14(1):35-43. PubMed ID: 7927959
    [Abstract] [Full Text] [Related]

  • 10. Angiotensin converting enzyme inhibitors. Disparities in the mechanism of their antihypertensive effect.
    Garavaglia GE, Messerli FH, Nunez BD, Schmieder RE, Frohlich ED.
    Am J Hypertens; 1988 Jul; 1(3 Pt 3):214S-216S. PubMed ID: 2843195
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effects of angiotensin converting enzyme inhibition in adult polycystic kidney disease.
    Watson ML, Macnicol AM, Allan PL, Wright AF.
    Kidney Int; 1992 Jan; 41(1):206-10. PubMed ID: 1317477
    [Abstract] [Full Text] [Related]

  • 14. Effects of dual blockade of the renin-angiotensin system in primary proteinuric nephropathies.
    Luño J, Barrio V, Goicoechea MA, González C, de Vinuesa SG, Gómez F, Bernis C, Espinosa M, Ahijado F, Gómez J, Escalada P.
    Kidney Int Suppl; 2002 Dec; (82):S47-52. PubMed ID: 12410855
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The effects of lisinopril on renal function in proteinuric renal transplant recipients.
    Traindl O, Falger S, Reading S, Banyai M, Liebisch B, Gisinger J, Templ E, Mayer G, Kovarik J.
    Transplantation; 1993 Jun; 55(6):1309-13. PubMed ID: 8390733
    [Abstract] [Full Text] [Related]

  • 17. The renoprotective properties of angiotensin-converting enzyme inhibitors in a chronic model of membranous nephropathy are solely due to the inhibition of angiotensin II: evidence based on comparative studies with a receptor antagonist.
    Zoja C, Donadelli R, Corna D, Testa D, Facchinetti D, Maffi R, Luzzana E, Colosio V, Bertani T, Remuzzi G.
    Am J Kidney Dis; 1997 Feb; 29(2):254-64. PubMed ID: 9016898
    [Abstract] [Full Text] [Related]

  • 18. Renoprotective effect of small doses of losartan and enalapril in patients with primary glomerulonephritis. Short-term observation.
    Tylicki L, Rutkowski P, Renke M, Rutkowski B.
    Am J Nephrol; 2002 Feb; 22(4):356-62. PubMed ID: 12169868
    [Abstract] [Full Text] [Related]

  • 19. [Therapy with ACE inhibitors in chronic heart failure and limited kidney function].
    Osterziel KJ, Nagel F, Dietz R.
    Z Kardiol; 1994 Feb; 83 Suppl 4():81-7. PubMed ID: 7856286
    [Abstract] [Full Text] [Related]

  • 20. Renal hemodynamics and reduction of proteinuria by a vasodilating beta blocker versus an ACE inhibitor.
    Erley CM, Harrer U, Krämer BK, Risler T.
    Kidney Int; 1992 May; 41(5):1297-303. PubMed ID: 1614045
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.